Conv. Plasma
Nigella Sativa
Peg.. Lambda

All acetaminophen studies
Meta analysis
Home COVID-19 treatment researchAcetaminophenAcetaminophen (more..)
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta
Cannabidiol Meta Molnupiravir Meta
Colchicine Meta
Conv. Plasma Meta
Curcumin Meta Nigella Sativa Meta
Ensovibep Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Peg.. Lambda Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Ivermectin Meta
Lactoferrin Meta

All Studies   Meta Analysis   Recent:  
0 0.5 1 1.5 2+ Cardiovascular complicat.. -15% Improvement Relative Risk Renal failure -92% Acetaminophen  Jeong et al.  EARLY TREATMENT Is early treatment with acetaminophen beneficial for COVID-19? Retrospective study in South Korea (January - April 2020) Study compares with NSAIDs, results vs. placebo may differ No significant difference in outcomes seen Jeong et al., Clinical Infectious Dise.., Jul 2020 Favors acetaminophen Favors NSAIDs

Association Between Nonsteroidal Antiinflammatory Drug Use and Adverse Clinical Outcomes Among Adults Hospitalized With Coronavirus 2019 in South Korea: A Nationwide Study

Jeong et al., Clinical Infectious Diseases, doi:10.1093/cid/ciaa1056
Jul 2020  
  Source   PDF   All Studies   Meta AnalysisMeta
Retrospective 1,824 hospitalized COVID-19 patients in South Korea, showing higher progression to combined death, ICU, ventilation, or sepsis (4% versus 0%, group sizes not provided) with paracetamol vs. NSAIDs. Treatment time may vary - exposure was defined as 7 days before and including cohort entry in hospitalized COVID-19 patients. Paracetamol is also known as acetaminophen, Tylenol, Panadol, Calpol, Tempra, Calprofen, Doliprane, Efferalgan, Grippostad C, Dolo, Acamol, Fevadol, Crocin, and Perfalgan.
risk of miscellaneous, 14.9% higher, OR 1.15, p = 0.61, inverted to make OR<1 favor treatment, cardiovascular complications, RR approximated with OR.
risk of miscellaneous, 92.3% higher, OR 1.92, p = 0.53, inverted to make OR<1 favor treatment, acute renal failure, RR approximated with OR.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Jeong et al., 27 Jul 2020, retrospective, South Korea, peer-reviewed, 6 authors, study period 1 January, 2020 - 8 April, 2020, this trial compares with another treatment - results may be better when compared to placebo.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperAcetaminophenAll
Association Between Nonsteroidal Antiinflammatory Drug Use and Adverse Clinical Outcomes Among Adults Hospitalized With Coronavirus 2019 in South Korea: A Nationwide Study
Han Eol Jeong, Hyesung Lee, Hyun Joon Shin, Young June Choe, Kristian B Filion, Ju-Young Shin
Clinical Infectious Diseases, doi:10.1093/cid/ciaa1056
Background. Nonsteroidal antiinflammatory drugs (NSAIDs) may exacerbate coronavirus disease 2019 (COVID-19) and worsen associated outcomes by upregulating the enzyme that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) binds to in order to enter cells. Methods. We conducted a cohort study using South Korea's nationwide healthcare database, which contains data for all individuals who received a COVID-19 test (n = 69 793) as of 8 April 2020. We identified adults hospitalized with COVID-19, where cohort entry was the date of hospitalization. NSAID users were those prescribed NSAIDs in the 7 days before and including cohort entry, and nonusers were those not prescribed NSAIDs during this period. Our primary outcome was a composite of in-hospital death, intensive care unit admission, mechanical ventilation use, and sepsis; our secondary outcomes were cardiovascular complications and acute renal failure. We conducted logistic regression analysis to estimate odds ratio (OR) with 95% confidence intervals (CIs) using inverse probability of treatment weighting to minimize confounding. Results. Of 1824 adults hospitalized with COVID-19 (mean age, 49.0 years; female, 59%), 354 were NSAID users and 1470 were nonusers. Compared with nonuse, NSAID use was associated with increased risks of the primary composite outcome (OR, 1.54; 95% CI, 1.13-2.11) but insignificantly associated with cardiovascular complications (OR, 1.54; 95% CI, 0.96-2.48) or acute renal failure (OR, 1.45; 95% CI, 0.49-4.14). Conclusions. While awaiting the results of confirmatory studies, we suggest NSAIDs be used with caution for COVID-19 patients as the harms associated with their use may outweigh their benefits.
Supplementary Data Supplementary materials are available at Clinical Infectious Diseases online. Consisting of data provided by the authors to benefit the reader, the posted materials are not copyedited and are the sole responsibility of the authors, so questions or comments should be addressed to the corresponding author. Notes Author contributions. All authors contributed to the study design and interpretation of the data. H. E. J. and H. L. designed the study and interpreted the data. H. E. J. wrote the manuscript. H. L. conducted the statistical analyses. H. J. S., Y. J. C., and K. B. F. interpreted the data and critically revised the manuscript. All authors reviewed and commented on drafts, approved the final manuscript, and made the decision to submit it for publication. J-Y. S. is the guarantor. Acknowledgments. The authors thank healthcare professionals dedicated to treating coronavirus 2019 patients in South Korea, the Ministry of Health and Welfare, the Health Insurance Review & Assessment Service, and Do-Yeon Cho of the Health Insurance Review & Assessment Service of South Korea for sharing invaluable national health insurance claims data in a prompt manner. Disclaimer. The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the manuscript. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication. Financial..
Bancos, Bernard, Topham, Phipps, Ibuprofen and other widely used non-steroidal anti-inflammatory drugs inhibit antibody production in human cells, Cell Immunol
Bhala, Emberson, Merhi, Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials, Lancet
Caughey, Cleland, Penglis, Gamble, James, Roles of cyclooxygenase (COX)-1 and COX-2 in prostanoid production by human endothelial cells: selective up-regulation of prostacyclin synthesis by COX-2, J Immunol
Clavé, Rousset-Rouvière, Daniel, Tsimaratos, The invisible threat of non-steroidal anti-inflammatory drugs for kidneys, Front Pediatr
Desai, Franklin, Alternative approaches for confounding adjustment in observational studies using weighting based on the propensity score: a primer for practitioners, BMJ
Fang, Karakiulakis, Roth, Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?, Lancet Respir Med
Fung, Yuen, Ye, Chan, Jin, A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses, Emerg Microbes Infect
Hoffmann, Kleine-Weber, Schroeder, SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor, Cell
Huang, Zhang, Zhang, Rapid asymptomatic transmission of COVID-19 during the incubation period demonstrating strong infectivity in a cluster of youngsters aged 16-23 years outside Wuhan and characteristics of young patients with COVID-19: a prospective contact-tracing study, J Infect
Inaoka, Kimishima, Takahashi, Shiohara, Non-steroidal antiinflammatory drugs selectively inhibit cytokine production by NK cells and gamma delta T cells, Exp Dermatol
Kim, Yoon, Kim, Kim, Towards actualizing the value potential of Korea Health Insurance Review and Assessment (HIRA) Data as a resource for health research: strengths, limitations, applications, and strategies for optimal use of HIRA data, J Korean Med Sci
Kuba, Imai, Rao, A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury, Nat Med
Lee, Cheung, Nicholls, Hyperinduction of cyclooxygenase-2-mediated proinflammatory cascade: a mechanism for the pathogenesis of avian influenza H5N1 infection, J Infect Dis
Li, Moore, Vasilieva, Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus, Nature
Little, Non-steroidal anti-inflammatory drugs and covid-19, BMJ, doi:10.1136/bmj.m1185
Moride, Abenhaim, Yola, Lucein, Evidence of the depletion of susceptibles effect in non-experimental pharmacoepidemiologic research, J Clin Epidemiol
Qiao, Wang, Chen, Ibuprofen attenuates cardiac fibrosis in streptozotocin-induced diabetic rats, Cardiology
Schmidt, Lamberts, Olsen, Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the Working Group for Cardiovascular Pharmacotherapy of the European Society of Cardiology, Eur Heart J
Suissa, Immortal time bias in pharmaco-epidemiology, Am J Epidemiol
Voiriot, Philippot, Elabbadi, Elbim, Chalumeau et al., Risks related to the use of non-steroidal anti-inflammatory drugs in communityacquired pneumonia in adult and pediatric patients, J Clin Med
Wen, Hsiao, Chan, Lin, Shen et al., Acute respiratory infection and use of nonsteroidal anti-inflammatory drugs on risk of acute myocardial infarction: a nationwide case-crossover study, J Infect Dis
Wen, Hsiao, Lin, Fang, Shen, Risk of stroke associated with use of nonsteroidal anti-inflammatory drugs during acute respiratory infection episode, Pharmacoepidemiol Drug Saf
Zhang, Donnan, Bell, Guthrie, Non-steroidal anti-inflammatory drug induced acute kidney injury in the community dwelling general population and people with chronic kidney disease: systematic review and meta-analysis, BMC Nephrol
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop